Chemoprophylaxis and Plasmodium Falciparum NF54 Sporozoite Immunization Challenged by Heterologous Infection

NCT02098590 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

40

Enrollment

OTHER

Sponsor class

Conditions

Malaria

Interventions

BIOLOGICAL: CPS-immunization
BIOLOGICAL: malaria challenge infection, P. falciparum NF135.C10
BIOLOGICAL: malaria challenge infection, P. falciparum NF166.C8
BIOLOGICAL: malaria challenge infection, P. falciparum NF54
DRUG: atovaquone/proguanil

Sponsor

Radboud University Medical Center

Collaborators

[object Object]